These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17598435)

  • 81. Relationship between high incidence of adverse dapsone reactions and slow acetylate phenotype or low plasma/lymphocyte glutathione level.
    Guo R; Thormann W; Lauterberg B
    Chin Med J (Engl); 1996 Dec; 109(12):933-6. PubMed ID: 9275325
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Mapping local hippocampal changes in Alzheimer's disease and normal ageing with MRI at 3 Tesla.
    Frisoni GB; Ganzola R; Canu E; Rüb U; Pizzini FB; Alessandrini F; Zoccatelli G; Beltramello A; Caltagirone C; Thompson PM
    Brain; 2008 Dec; 131(Pt 12):3266-76. PubMed ID: 18988639
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Sparteine oxidation polymorphism in Greenlanders living in Denmark.
    Brøsen K
    Br J Clin Pharmacol; 1986 Oct; 22(4):415-9. PubMed ID: 3768256
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Aminopyrine metabolism in man: the acetylation of aminoantipyrine cosegregates with acetylation of caffeine.
    Agúndez JA; Carrillo JA; Martínez C; Benítez J
    Ther Drug Monit; 1995 Feb; 17(1):1-5. PubMed ID: 7725368
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Undernourished adults and acetylation phenotype.
    Arunkumar Shastri R
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):194-6. PubMed ID: 7076349
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [A serogenetic approach to the study of Alzheimer's disease (author's transl)].
    Mehne P; Grünwald P; Gerner-Beuerle E
    Aktuelle Gerontol; 1976 Jun; 6(6):259-66. PubMed ID: 14530
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: nonlinearity and relation to the sparteine oxidation polymorphism.
    Sindrup SH; Brøsen K; Gram LF
    Clin Pharmacol Ther; 1992 Mar; 51(3):288-95. PubMed ID: 1531951
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effect of physical training on sulfamethazine acetylation rate.
    Abzalov RA; Nigmatullina RR; Khairullina GN; Garmonov SY; Shakirova LS; Evgen'ev MI
    Bull Exp Biol Med; 2000 Dec; 130(12):1141-3. PubMed ID: 11276304
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Polymorphisms at the beta2-adrenergic receptor gene influence Alzheimer's disease susceptibility.
    Yu JT; Tan L; Ou JR; Zhu JX; Liu K; Song JH; Sun YP
    Brain Res; 2008 May; 1210():216-22. PubMed ID: 18423577
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Relationship between acetylator phenotype and intensity of the hypoglycaemic effect of a suplhonamide preparation in children with insulin-dependent diabetes.
    Hadasová E; Brysová V; Utĕsený J; Macků M
    Bratisl Lek Listy; 1991 Dec; 92(12):609-14. PubMed ID: 1806177
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effects of nocloprost (9 beta-chloro-16,16-dimethyl PG E2) on absorption and disposition of antipyrine and sulfamethazine in healthy volunteers.
    Siegmund W; Zschiesche M; Franke G; Müller C; Amon I
    Int J Clin Pharmacol Ther Toxicol; 1993 Apr; 31(4):190-7. PubMed ID: 8500921
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Distribution of acetylator phenotypes in the Moscow population].
    Lil'in ET; Korsunskaia MP; Meksin VA; Tarlycheva LV; Shapiro EF
    Genetika; 1983 Aug; 19(8):1378-80. PubMed ID: 6685091
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Isoniazid acetylation in a group of Tunisian patients. Report of 620 patients].
    Mehiri BR; Zouaoui A; Chérif J; Ourari B; Daghfous R; Oueslati MH; Louzir B; Daghfous J; Chelbi B; Béji M
    Tunis Med; 2005 Jul; 83(7):385-9. PubMed ID: 16220693
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Age-dependent association of KIBRA genetic variation and Alzheimer's disease risk.
    Rodríguez-Rodríguez E; Infante J; Llorca J; Mateo I; Sánchez-Quintana C; García-Gorostiaga I; Sánchez-Juan P; Berciano J; Combarros O
    Neurobiol Aging; 2009 Feb; 30(2):322-4. PubMed ID: 17707552
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Isoniazid acetylation phenotyping in Saudi Arabs.
    Matar KM; Mayet AY; Ayoola EA; Bawazir SA; Al-Faleh FZ; Al-Wazzan A
    J Clin Pharm Ther; 2004 Oct; 29(5):443-7. PubMed ID: 15482388
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Determination of the oxidation phenotype in the Czechoslovak population using metoprolol].
    Ulc I; Ulc J; Cepeláková H
    Cas Lek Cesk; 1990 Feb; 129(8):244-6. PubMed ID: 2331742
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Acetylation processes in chronic alcoholics].
    Kovalev IE; Kovalev EN; Seleznev NG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):232-4. PubMed ID: 6711211
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Neuropsychological assessment of cognitive function in chronic alcohol-dependent patients and patients with Alzheimer's disease.
    Liappas I; Theotoka I; Kapaki E; Ilias I; Paraskevas GP; Soldatos CR
    In Vivo; 2007; 21(6):1115-8. PubMed ID: 18210766
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Low vitamin K intakes in community-dwelling elders at an early stage of Alzheimer's disease.
    Presse N; Shatenstein B; Kergoat MJ; Ferland G
    J Am Diet Assoc; 2008 Dec; 108(12):2095-9. PubMed ID: 19027415
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.
    Gouw AA; Seewann A; Vrenken H; van der Flier WM; Rozemuller JM; Barkhof F; Scheltens P; Geurts JJ
    Brain; 2008 Dec; 131(Pt 12):3286-98. PubMed ID: 18927145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.